Screened 2026-09-09 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its accumulation label.
Sociedad Química y Minera de Chile S.A. holds its Accumulation at $75.46. The statistical read favours the sellers, held for 5 days.
As held on the ledger · 2026-09-09
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 5 days
Price at the screen
$75.46
Valuation
15.53 trailing · 11.23 forward price to earnings
Values screen
PASS
Beta
1.02
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.76%
Below 33%
Interest-bearing debt is just 20.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
11.86%
Below 33%
Cash held in interest-bearing accounts and securities is 11.9% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 4.2% above the base estimate.
Third-party analyst targets: 18 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Battery boom meets a classic cyclical trap
Picture the rush for lithium and fertilisers as electric cars and crops both surge. SQM sits right in that flow, posting 70% revenue growth and a 15% profit margin while clearing our ethical screen without issues. The forward multiple sits at 10.7 times and the shares trade only a couple of percent below our fair value, which on paper looks reasonable.
Yet the business carries a weak moat and just 13% return on equity. In a cyclical industry those figures often reflect peak conditions rather than durable strength. Low multiples in mining frequently signal the top of the cycle, not an entry point.
The real danger is earnings compression once commodity prices normalise. A weak competitive position leaves little room if volumes or prices turn. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SQM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 7.1% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 120%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (18 analysts) rates it buy, with a mean price target of $79.
2026-07-18Markdown$75.43+0.0%Entry 3
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 120%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (18 analysts) rates it buy, with a mean price target of $79.
2026-07-03Markdown$75.43+0.0%Entry 2
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Markdown$75.43Entry 1
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
